Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes

被引:29
作者
Brocke, P [1 ]
Armandola, E [1 ]
Garbi, N [1 ]
Hämmerling, GJ [1 ]
机构
[1] DKFZ, German Canc Res Ctr, D-69120 Heidelberg, Germany
关键词
antigen presentation; H2-O; HLA-DO;
D O I
10.1002/immu.200310015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Peptide loading onto MHC class II molecules takes place in endosomal compartments along the endocytic pathway. There, loading is facilitated by the catalytic function of the accessory molecule H2-M, which helps to exchange the invariant chain-derived CLIP peptide in the groove of class II molecules for antigenic peptide. H2-O is another accessory molecule specific to the class II pathway, which is found tightly associated with H2-M and selectively expressed in B cells. Using stable H2-O ribozyme-antisense transfectants, H2-O overexpressing murine B cell lines, and H2-O-transgenic mice, we investigated the effects of H2-O on antigen presentation. The results show that presentation of a variety of exogenous protein antigens to a panel of T cell hybridomas depended on the levels of H2-O in the antigenpresenting B cells. Thus, increased H2-O expression downmodulated, whereas reduced H2-O levels, enhanced presentation. Presentation of endogenous antigen was also diminished by H2-O. Despite the pronounced effects on antigen presentation, the mass spectrometric profiles of peptides eluted from A(b) molecules were very similar in cells expressing different H2-O levels. The intracellular location of H2-O inhibitory activity was investigated with the drug chloroquine, which prevents acidification of the endocytic pathway. The observations indicate that H2-O predominantly inhibits antigen presentation in early endosomal compartments. Thus, H2-O appears to skew peptide loading to late endosomal/lysosomal compartments. This may favor presentation of antigens taken up by the B cell receptor.
引用
收藏
页码:411 / 421
页数:11
相关论文
共 44 条
  • [1] INTERACTION OF AN IMMUNODOMINANT EPITOPE WITH IA MOLECULES IN T-CELL ACTIVATION
    ADORINI, L
    SETTE, A
    BUUS, S
    GREY, HM
    DARSLEY, M
    LEHMANN, PV
    DORIA, G
    NAGY, ZA
    APPELLA, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (14) : 5181 - 5185
  • [2] Nonclassical MHC class II molecules
    Alfonso, C
    Karlsson, L
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 : 113 - +
  • [3] Functional HLA-DM on the surface of B cells and immature dendritic cells
    Arndt, SO
    Vogt, AB
    Markovic-Plese, S
    Martin, R
    Moldenhauer, G
    Wölpl, A
    Sun, YS
    Schadendorf, D
    Hämmerling, GJ
    Kropshofer, H
    [J]. EMBO JOURNAL, 2000, 19 (06) : 1241 - 1251
  • [4] The structure, function and application of the hammerhead ribozyme
    Birikh, KR
    Heaton, PA
    Eckstein, F
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 245 (01): : 1 - 16
  • [5] BRAMLAGE B, 1997, BIOFORUM, V4, P134
  • [6] HLA-DM, HLA-DO and tapasin:: functional similarities and differences
    Brocke, P
    Garbi, N
    Momburg, F
    Hämmerling, GJ
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2002, 14 (01) : 22 - 29
  • [7] Regulated expression of human histocompatibility leukocyte antigen (HLA)-DO during antigen-dependent and antigen-independent phases of B cell development
    Chen, XJ
    Laur, O
    Kambayashi, T
    Li, SY
    Bray, RA
    Weber, DA
    Karlsson, L
    Jensen, PE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (08) : 1053 - 1062
  • [8] Negative regulation by HLA-DO of MHC class II-restricted antigen processing
    Denzin, LK
    SantAngelo, DB
    Hammond, C
    Surman, MJ
    Cresswell, P
    [J]. SCIENCE, 1997, 278 (5335) : 106 - 109
  • [9] HLA-DO is an intracellular class II molecule with distinctive thymic expression
    Douek, DC
    Altmann, DM
    [J]. INTERNATIONAL IMMUNOLOGY, 1997, 9 (03) : 355 - 364
  • [10] A study of complexes of class II invariant chain peptide: Major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody
    Eastman, S
    Deftos, M
    DeRoos, PC
    Hsu, DH
    Teyton, L
    Braunstein, NS
    Hackett, CJ
    Rudensky, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (02) : 385 - 393